RheumaGen Featured on in Fitzsimons Innovation Community “Innovation Spotlight”
RheumaGen’s paradigm-shifting work in HLA gene editing was recently highlighted by the Fitzsimons Innovation Community. Read more here.
Previous
Previous
RheumaGen CEO Richard Freed to Speak at Mountain West BioLife Summit
Next
Next